Bill
Bill > SB805
MD SB805
MD SB805Maryland Medical Assistance Program and Health Insurance – Required Coverage for Biomarker Testing
summary
Introduced
02/06/2023
02/06/2023
In Committee
04/05/2023
04/05/2023
Crossed Over
03/20/2023
03/20/2023
Passed
04/10/2023
04/10/2023
Dead
Signed/Enacted/Adopted
05/03/2023
05/03/2023
Introduced Session
2023 Regular Session
Bill Summary
AN ACT concerning Maryland Medical Assistance Program and Health Insurance - Required Coverage for Biomarker Testing FOR the purpose of requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, health maintenance organizations, and managed care organizations to provide coverage for biomarker testing that is supported by medical and scientific evidence; establishing requirements for deductibles, copayments, coinsurance, and utilization review for biomarker testing; and generally relating to the coverage of biomarker testing by the Maryland Medical Assistance Program and health insurance carriers. BY adding to Article - Health - General Section 15-102.3(k) and 15-103(a)(2)(xxii) Annotated Code of Maryland (2019 Replacement Volume and 2022 Supplement) BY repealing and reenacting, without amendments, Article - Health - General Section 15-103(a)(1) Annotated Code of Maryland (2019 Replacement Volume and 2022 Supplement) BY repealing and reenacting, with amendments, Article - Health - General Section 15-103(a)(2)(xx) and (xxi) Annotated Code of Maryland (2019 Replacement Volume and 2022 Supplement) BY adding to Article - Insurance Section 15-859 Annotated Code of Maryland (2017 Replacement Volume and 2022 Supplement)
AI Summary
This bill requires the Maryland Medical Assistance Program and certain health insurers to provide coverage for biomarker testing that is supported by medical and scientific evidence. Biomarker testing is the analysis of a patient's tissue, blood, or other biospecimen to provide information that can be used to formulate a treatment or monitoring strategy. The bill establishes requirements for deductibles, copayments, coinsurance, and utilization review for this coverage. The bill also requires the Maryland Department of Health to report on the fiscal impact and access to biomarker testing in the Maryland Medical Assistance Program, and the Maryland Health Care Commission to report on the impact of providing this coverage.
Committee Categories
Budget and Finance, Health and Social Services
Sponsors (1)
Last Action
Approved by the Governor - Chapter 322 (on 05/03/2023)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/SB0805?ys=2023RS |
| BillText | https://mgaleg.maryland.gov/2023RS/Chapters_noln/CH_322_sb0805e.pdf |
| BillText | https://mgaleg.maryland.gov/2023RS/bills/sb/sb0805e.pdf |
| Favorable with Amendments 633326/1 Adopted | https://mgaleg.maryland.gov/2023RS/amds/bil_0005/sb0805_63332601.pdf |
| Vote Image | https://mgaleg.maryland.gov/2023RS/votes_comm/sb0805_hgo.pdf |
| BillText | https://mgaleg.maryland.gov/2023RS/bills/sb/sb0805t.pdf |
| Floor Amendment 713728/1 (Senator Ellis) Adopted | https://mgaleg.maryland.gov/2023RS/amds/bil_0005/sb0805_71372801.pdf |
| Favorable with Amendments 723223/1 Adopted | https://mgaleg.maryland.gov/2023RS/amds/bil_0005/sb0805_72322301.pdf |
| Vote Image | https://mgaleg.maryland.gov/2023RS/votes_comm/sb0805_fin.pdf |
| BillText | https://mgaleg.maryland.gov/2023RS/bills/sb/sb0805f.pdf |
Loading...